Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cardesa

Showing results (321-330 of 338) with videos related to

Pageof 34
Sort By:
Haematologica|May 30, 2013
MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapyAlexandra Valera, Armando López-Guillermo, Teresa Cardesa-Salzmann, et al.
Virchows Archiv : an International Journal of Pathology|February 6, 2026
miRNA profiling in pediatric and young adult Burkitt leukemia and lymphomaBjörn Schneider, Caterina Redwanz, Veronica Celis, et al.
Archivos Espanoles De Urologia|March 3, 2026
Surgical and Functional Outcomes after Perineal Approach for Repair of Vesico-Urethral Anastomotic Stenosis Following Radical ProstatectomySandra San Cayetano Talegón, Felix Campos-Juanatey, Paola Calleja Hermosa, et al.
Blood|March 29, 2011
Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapyGonzalo Gutiérrez-García, Teresa Cardesa-Salzmann, Fina Climent, et al.
Haematologica|May 7, 2011
High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapyTeresa M Cardesa-Salzmann, Luis Colomo, Gonzalo Gutierrez, et al.
Plos One|May 17, 2018
Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility studyOscar Fernández, Guillermo Izquierdo, Victoria Fernández, et al.
Head & Neck|June 5, 2015
Neuroendocrine neoplasms of the sinonasal regionDiana Bell, Ehab Y Hanna, Randal S Weber, et al.
Blood|June 29, 2012
A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphomaAnamarija M Perry, Teresa M Cardesa-Salzmann, Paul N Meyer, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 17, 2016
Design and application of a 23-gene panel by next-generation sequencing for inherited coagulation bleeding disordersJ M Bastida, M Del Rey, M L Lozano, et al.
Journal of Clinical Medicine|November 9, 2024
Platelet Responses After Tapering and Discontinuation of Fostamatinib in Patients with Immune Thrombocytopenia: A Continuation of the Fostasur StudyMaría Eva Mingot-Castellano, Gloria García-Donas, Rosa María Campos-Álvarez, et al.
Pageof 34

Showing results (321-330 of 338) with videos related to

Sort By:
Pageof 34
Haematologica|May 30, 2013
MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapyAlexandra Valera, Armando López-Guillermo, Teresa Cardesa-Salzmann, et al.
Virchows Archiv : an International Journal of Pathology|February 6, 2026
miRNA profiling in pediatric and young adult Burkitt leukemia and lymphomaBjörn Schneider, Caterina Redwanz, Veronica Celis, et al.
Archivos Espanoles De Urologia|March 3, 2026
Surgical and Functional Outcomes after Perineal Approach for Repair of Vesico-Urethral Anastomotic Stenosis Following Radical ProstatectomySandra San Cayetano Talegón, Felix Campos-Juanatey, Paola Calleja Hermosa, et al.
Blood|March 29, 2011
Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapyGonzalo Gutiérrez-García, Teresa Cardesa-Salzmann, Fina Climent, et al.
Haematologica|May 7, 2011
High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapyTeresa M Cardesa-Salzmann, Luis Colomo, Gonzalo Gutierrez, et al.
Plos One|May 17, 2018
Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility studyOscar Fernández, Guillermo Izquierdo, Victoria Fernández, et al.
Head & Neck|June 5, 2015
Neuroendocrine neoplasms of the sinonasal regionDiana Bell, Ehab Y Hanna, Randal S Weber, et al.
Blood|June 29, 2012
A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphomaAnamarija M Perry, Teresa M Cardesa-Salzmann, Paul N Meyer, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 17, 2016
Design and application of a 23-gene panel by next-generation sequencing for inherited coagulation bleeding disordersJ M Bastida, M Del Rey, M L Lozano, et al.
Journal of Clinical Medicine|November 9, 2024
Platelet Responses After Tapering and Discontinuation of Fostamatinib in Patients with Immune Thrombocytopenia: A Continuation of the Fostasur StudyMaría Eva Mingot-Castellano, Gloria García-Donas, Rosa María Campos-Álvarez, et al.
Pageof 34